Funding Details
- Awarder
- Inbox
- Date Award
- December 18, 2024
- Vertical
- Biotech
- Funding URL
- View Funding Page
- Funding Amount:
-
$22,500,000
Company Info
- Traction
- Completed enrollment in the safety run-in portion of the Phase 1 clinical trial of IDP-023.
- Founders
- Mark Frohlich
- Company Description
- Indapta Therapeutics is a privately held biotechnology company.
- Market
- Healthcare
- Location
-
Houston,
Texas,
USA
- Coinvestors
- RA Capital Management, LP, Leaps by Bayer, Vertex Ventures HC, Pontifax, Myeloma Investment Fund
Links